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background:  Iron deficiency is highlighted as an important therapeutic target in recent heart failure (HF) guidelines. However, prior studies were 
limited to mainly Caucasian populations and HF with reduced ejection fraction (HFrEF). We aimed to study the functional and prognostic significance 
of functional iron deficiency (FID) in Asian patients with HFrEF and HF with preserved ejection fraction (HFpEF).
Methods:  Transferrin saturation (Tsat) was measured in 740 patients enrolled in a prospective nationwide longitudinal HF study in Singapore.
results:  FID was present in 472 (64%) of patients with HF (65% in HFrEF, 60% in HFpEF; p=0.30). There was no association between the presence 
of FID and anemia, with 215 patients having FID without anemia, and 84 patients having anemia without FID. At baseline, patients with FID had 
worse functional status as measured by New York Heart Association Class and higher Minnesota Living With Heart Failure Scores than those without 
FID (Figure 1). Over a median follow up of 307 days, there were 196 events (HF hospitalization or death). Low Tsat was associated with greater risk 
of events (p=0.019) even after adjusting for age, sex and comorbidities. There was no interaction between FID and HF group. Patients with both FID 
and anemia (N=224) had the poorest prognosis (Figure 2).
conclusions:  FID is present in the majority of Asian HF patients regardless of EF. The functional and prognostic impact of FID suggests that it is an 
important therapeutic target in Asian patients with HF.
 
